What Nunatak Biotech does

Nunatak Biotech is an Argentine biotechnology company founded in 2023 that designs biological crop inputs derived from extremophile microorganisms isolated from Antarctica and other polar environments. The company's core technology is a platform that combines microbiology with bioinformatics to characterize extremophile microbiomes and design functional microbial consortia capable of improving plant performance under abiotic stresses such as cold, salinity, and soil degradation. Its commercial product line is branded Yamana and comprises three SKUs: the core Yamana biological enhancer with a triple-action mechanism combining a microbial consortium, micronutrition, and organic amendment functioning as both biofertilizer and biostimulant; Yamana Cold, a microbial seed treatment built on the proprietary Pseudomonas fluorescens NB1 strain isolated from Antarctica for cold-stress tolerance in soybean, wheat, corn, and potato; and the forthcoming Yamana Terra, designed for plant establishment in saline and stressed soils.

The company serves large agribusinesses and farmers as its primary customer segment, with secondary segments in food and beverage companies seeking supply-chain resilience and in land restoration and remediation projects targeting degraded soils. Its go-to-market is enterprise field sales, with direct engagement on pilot programs and field-scale validation alongside a partner network of agricultural input companies; products are positioned as fully stackable with existing chemical seed treatments and compatible with other biological inputs to lower adoption friction. Pricing is not publicly disclosed.

Nunatak operates with a small team of approximately 1–10 employees led by four co-founders — Julia Mensa (CEO), Lucas Ruberto (R&D Head), Martha Martorell (COO), and Francisco Massot (CTO) — supported by a Science & Tech team, a Business team, partners, and an advisor. The company is privately held, headquartered in Argentina, has participated in at least four accelerator programs between 2024 and 2026 (including GRID EXPONENTIAL, SVG Ventures, Eatable Adventures, and Agrofood BIC), and reports no public revenue disclosures or patents in the source material.

Name

Nunatak Biotech

Legal name

Nunatak Biotech

Website

https://nunatakbio.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Nunatak Biotech is an Argentine biotech startup that develops microbial bioinputs derived from Antarctic extremophiles to improve crop performance under abiotic stress, serving agribusinesses, farmers, and land restoration projects through pilot-stage field sales.

Ownership category

akta.pro rank

Product category

Agricultural Biologicals

NAICS

Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253), Pesticide and Other Agricultural Chemical Manufacturing (32532)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Biostimulants & Plant Health Biologicals (Microbial/Non-microbial) (AFABAEAK)

akta.pro secondary industries

Biofertilizers & Microbial Inoculants (IMAEAEAG), Biological Formulation, Fermentation & Scale-Up Manufacturing (AFABAEAM)

Keywords

• Agricultural biological inputs
• Microbial seed treatments
• Soil restoration solutions
• Abiotic stress management
• Biofertilizer products

Headquarters

HQ city

Buenos Aires

HQ country

Argentina

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Biological Seed Treatments: Sale of microbial seed treatment products (Yamana Cold, Yamana Terra) to farmers and agribusiness companies for improving crop establishment and performance under stress conditions. Products are sold as liquid seed treatments with low-dose efficiency.
2. Bioinputs for Land Restoration: Sale of biological solutions for land restoration and remediation projects targeting degraded soils and long-term soil-plant health rebuilding.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Nunatak Biotech develops and manufactures biological agricultural inputs (biofertilizers, biostimulants, and microbial seed treatments) derived from extremophile microorganisms sourced from Antarctica and other extreme environments. The company's products, marketed under the YAMANA brand, combine microbial consortia with micronutrition and organic amendments to improve crop tolerance to abiotic stresses such as cold, salinity, and soil degradation.

Product overview

Nunatak Biotech offers a platform-based approach to biological solutions for agriculture and land restoration. Their flagship product line YAMANA includes YAMANA (core biological enhancer for crop establishment with triple-action mechanism: microbial consortium, micronutrition, and organic amendment), YAMANA Cold (microbial seed treatment for cold stress tolerance using Pseudomonas fluorescens NB1 isolated from Antarctica), and the upcoming Yamana Terra (biological solution for plant establishment in saline soils). All products leverage extremophile microorganisms from extreme environments to improve plant tolerance to abiotic stress.

Differentiator

Problem solved

Functional benefit

Brands

• Yamana: First biological enhancer product from Nunatak's platform designed for yield improvement and crop establishment. Includes Yamana Cold - a microbial seed treatment formulated with Pseudomonas fluorescens NB1 for cold stress conditions.
• Yamana Cold
• Yamana Terra

Products and services

• YAMANA YAMANA is a biological enhancer for crop establishment with a triple-action mechanism combining a microbial consortium, micronutrition, and an organic regenerator (amendment). It functions as both a biofertilizer and biostimulant, with modes of action including biological nitrogen fixation, phosphate solubilization, biofilm formation, and biocontrol of fungal phytopathogens. Target crops include wheat, barley, soybean, and pastures. Sold to agribusinesses and farmers.
• YAMANA Cold YAMANA Cold is a microbial seed treatment formulated with Pseudomonas fluorescens NB1, a native strain isolated from Antarctica naturally adapted to thrive under cold stress. Applied before sowing, it promotes uniform germination and early crop establishment under low-temperature conditions, supporting soybean, wheat, corn, and potato crops. Fully stackable with chemical seed treatments and compatible with selected biological inputs. Sold to agribusinesses and farmers.

Quantifiable outcome

• 50% of irrigated land becomes salinized
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• AcceleratorscoreOthersNunatak collaborates with accelerators as part of their ecosystem, having been selected by leading agrifood and climate innovation programs. They participated in 236+ international programs and accelerators.
• Corporate PartnerscoreStrategic or Co-development PartnerCorporate partners collaborating with Nunatak in their ecosystem to transform agriculture and restore soils through biological solutions.
• Innovation HubscoreStrategic or Co-development PartnerInnovation hubs part of Nunatak's collaborative ecosystem for transforming agriculture and developing biological solutions.
• Research InstitutionscoreStrategic or Co-development PartnerResearch institutions collaborating with Nunatak, supporting the scientific foundation of their extreme microbiome platform and product development.
• WeInvest and Emprendedoras LACminorGTM or Marketing PartnerAccelerators that organized the event in Buenos Aires where Nunatak (along with EYWA and Cromodata) presented their ventures, aiming to bridge gender gaps in Latin America's venture capital ecosystem.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Puna Bio: Argentine biotech developing extremophile (including Andean/Atacama-derived) microbial biofertilizers for stressed soils. Closest direct comparable to Nunatak: same Argentine origin, same extremophile-to-agriculture thesis, same broad-acre row crop focus.
• Symborg: Spanish manufacturer of microbial biofertilizers and biostimulants (e.g., Mycoshell, Trichoderma-based products). Closely comparable in product category (microbial biostimulants/biofertilizers) and go-to-market (partner-driven distribution to agribusiness), though larger and more global.
• Indigo Ag: US-based ag biotech commercializing microbial seed treatments and biostimulants (e.g., Indigo's biotrinsic portfolio) targeted at row crops. Directly competes in the microbial seed treatment category that YAMANA Cold targets.
• Pivot Bio: US-based microbial nitrogen-fixation company whose products (ProveN, ProveN 40, ReturN) overlap with the biofertilizer/biostimulant mechanism of YAMANA. Comparable in targeting row crops with a microbial mode of action that supplements or replaces conventional nitrogen inputs.
• AgBiome: US-based biological crop protection and input company using microbial discovery to develop agricultural products (e.g., Howler fungicide, AgBiomeLabs). Comparable as a microbial-discovery platform turned product company, with a similar biological-input go-to-market.
• Sound Agriculture: US-based company developing microbial and on-demand nutrient solutions for row crops. Comparable in product category (microbial + nutrient combination) and target customer (broad-acre agribusiness growers).
• BioConsortia: US-based microbial discovery and product company developing seed treatments and in-furrow biologicals. Comparable as a microbial-consortium platform company focused on row crop biological inputs.
• Locus Agricultural Solutions: US-based producer of microbial soil and seed treatments (e.g., Rhizo-L, Fungi-Act) targeting broad-acre crops. Comparable in offering microbial-based biological inputs and in working with agribusiness distribution channels.

Broad incumbents

• Bioceres: Argentina-based agricultural biotechnology company with biological-input adjacencies (including Rizobacter) and trait platforms (HB4). Larger incumbent that competes for the same Argentine/LATAM agribusiness customer base and validates the market for biological inputs in the region.
• Novonesis (formerly Novozymes): Global microbial and enzyme powerhouse with a dedicated agriculture biological-input business. Broad incumbent in the same product category; does not specialize in extremophile-sourced consortia but sets the pricing and channel benchmark for microbial ag inputs.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/nunatak-bio
• Instagraminstagram.com/nunatakbio

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nunatak Biotech